Search Browse Earnings

SCYNEXIS INC — SlamSEC

SCYNEXIS INC

Nasdaq:SCYX

Pharmaceutical Preparations·JERSEY CITY, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$3.7M

-97.3% YoY

FY 2025

Adj. EBITDA

-$36.5M

-975.4% margin

FY 2025

Net Income

-$21.3M

-568.3% margin

FY 2025

EPS (Diluted)

-$0.44

FY 2025

Stock Price

$0.86

+7.5%

2026-03-09

52W Range

$0.56 – $1.31

P/E Ratio

-2.0x

Market Cap

$38.4M

Cash

$16.1M

FY 2025

Total Debt

$15.1M

FY 2019

Net Cash

$969,000

FY 2019

Enterprise Value

$37.4M

Debt / EBITDA

0.0x

FY 2025

EV / EBITDA

-1.0x

Employees

—